Blood transfusions in children: A multi-institutional analysis of practices and complications

Transfusion

Volumn 48, Issue 1, 2008, Pages 73-80

  Slonim, Anthony D ^a   Joseph, Jill G ^b   Turenne, Wendy M ^b   Sharangpani, Aditi ^b   Luban, Naomi L C ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGRANULOCYTOSIS; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; BLOOD TRANSFUSION; CHILD; CHILD CARE; CLINICAL TRIAL; EPIDEMIOLOGICAL DATA; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; RISK FACTOR; SAFETY; SICKLE CELL; THROMBOCYTE TRANSFUSION;

AGRANULOCYTOSIS; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COSTS AND COST ANALYSIS; EPIDEMIOLOGIC METHODS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; NEUTROPENIA; PLATELET TRANSFUSION;

EID: 37549005191     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01484.x     Document Type: Article

References (47)

1. The 2005 nationwide blood collection and utilization survey report [Internet, accessed 2007 Aug 27].Available from: http://www.aabb.org/apps/docs/ 05nbcusrpt.pdf
2. Sullivan MT, McCullough J, Schreiber GB, Wallace EL. Blood collection and transfusion in the United States in 1997. Transfusion 2002 42 : 1253 60.
3. Roseff SD, Luban NL, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002 42 : 1398 413.
4. Sacher RA, Luban NLC, Strauss RG. Current practice and guidelines for the transfusion cellular blood components in the newborn. Transfus Med Rev 1989 3 : 39 54.
5. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, Cress GA, Johnson KJ, Kromer IJ, Zimmerman MB. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005 115 : 1685 91.
6. Strauss RG, Levy GJ, Sotelo-Avila C, Albanese MA, Hume H, Schloz L, Blazina J, Werner A, Barrasso C, Blanchette V, Warkentin PI, Pepkowitz S, Mauer AM, Hines D. National survey of neonatal transfusion practices: II. Blood component therapy. Pediatrics 1993 91 : 530 6.
7. Rebulla P. Platelet transfusion triggers in difficult patients. Transfus Clin Biol 2001 8 : 249 54.
8. French CJ, Bellomo R, Finfer SR, Lipman J, Chapman M, Boyce NW. Appropriateness of red blood cell transfusion in Australasian intensive care practice. Med J Aust 2002 177 : 548 51.
9. Solheim BG, Wesenberg F. Rational use of blood products. Eur J Cancer 2001 37 : 2421 5.
10. Luban NL. Transfusion safety: where are we today? Ann N Y Acad Sci 2005 1054 : 325 41.
11. Goodman AM, Pollack MM, Patel KM, Luban NL. Pediatric red blood cell transfusions increase resource use. J Pediatr 2003 142 : 123 7.
12. Bendixen H, Manning F, Sparacino L, editors. Blood and blood products: safety and risk. Washington (DC) : National Academies Press 1996.
13. Hébert PC, Fergusson DA, McIntyre LL, Martin C, Doucette S, Blajchman M, Graham ID The Canadian Critical Care Trials Group. Revisiting transfusion practices in critically ill patients. Crit Care Med 2005 33 : 7 12.
14. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet 2003 361 : 161 9.
15. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D ABC Investigators. Anemia and blood transfusion in critically ill patients. JAMA 2002 288 : 1499 507.
16. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 2005 127 : 295 307.
17. Chiavetta JA, Herst R, Freedman J, Axcell TJ, Wall AJ, van Rooy SC. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996 36 : 699 706.
18. Vamvakas EC, Taswell HF. Epidemiology of blood transfusion. Transfusion 1994 34 : 464 70.
19. Warner DO, Warner MA, Schroeder DR, Offord KP, Maxson P, Santrach P. Changing transfusion practices in hip and knee arthroplasty. Transfusion 1998 38 : 738 44.
20. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber HC, O'Hara DA, Noveck H, Strom BL. Perioperative blood transfusion and postoperative mortality. JAMA 1998 279 : 199 205.
21. Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, D'Ambra MN, Mangano DT, Spiess BD. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998 88 : 327 33.
22. Surgenor DM, Churchill WH, Wallace EL, Rizzo RJ, McGurk S, Goodnough LT, Kao KJ, Koerner TA, Olson JD, Woodson RD. The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. Transfusion 1998 38 : 122 34.
23. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988 260 : 2700 3.
24. Levy GJ, Strauss RG, Hume H, Schloz L, Albanese MA, Blazina J, Werner A, Sotelo-Avila C, Barrasso C, Blanchette V. National survey of neonatal transfusion practices. I. Red blood cell therapy. Pediatrics 1993 91 : 523 9.
25. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002 42 : 37 43.
26. Chambers LA, Cohen DM, Davis JT. Transfusion patterns in pediatric open heart surgery. Transfusion 1996 36 : 150 4.
27. Ruggiero A, Riccardi R. Interventions for anemia in pediatric cancer patients. Med Pediatr Oncol 2002 39 : 451 4.
28. Duguid JK, Minards J, Bolton-Maggs PH. Incompatible plasma transfusions and haemolysis in children. BMJ 1999 318 : 176 7.
29. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR. Transfusion-transmitted bacterial infection in the United States 1998 through 2000. Transfusion 2001 41 : 1493 9.
30. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002 42 : 966 72.
31. Dodd RY. Bacterial contamination and transfusion safety: experience in the United States. Transfus Clin Biol 2003 10 : 6 9.
32. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003 349 : 1205 6.
33. Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Hervé P. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002 42 : 1356 64.
34. Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000 40 : 1207 13.
35. Love EM, Soldan K Serious Hazards of Transfusion Steering Group. SHOT annual report 2000-2002. London : Serious Hazards of Transfusion Group 2002. p. 1- 239.
36. McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatibile platelet sources. Am J Clin Pathol 1999 111 : 202 6.
37. Robillard P, Nawej KI, Jochem K. The Quebec hemovigilance system: description and results from the first two years. Transfus Apher Sci 2004 31 : 111 22.
38. Faber JC. Worldwide overview of existing haemovigilance systems. Transfus Apher Sci 2004 31 : 99 110.
39. Faber JC. Work of the European Haemovigilance Network (EHN). Transfus Clin Biol 2004 11 : 2 10.
40. Stainsby D. Haemovigilance in the United Kingdom and Europe. Hematol J 2004 5 Suppl 3 : S175 8.
41. Voak D, Chapman JF, Phillips P. Quality of transfusion practice beyond the blood transfusion laboratory is essential to prevent ABO-incompatible death. Transfus Med 2000 10 : 95 6.
42. Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003 111 : e661 5.
43. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Tranfus Med Rev 2003 17 : 120 62.
44. Blajchman MA. Bacterial contamination of cellular blood components: risks, sources and control. Vox Sang 2004 87 : S98 103.
45. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology (Am Soc Hematol Educ Program) 2003 1 : 575 89.
46. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005 18 : 195 204.
47. The President's Advisory Commission on Consumer Protection and Quality in the Healthcare Industry. Quality first: better healthcare for all Americans. Washington (DC) : US Government Printing Office 1999.